Better late than never? The European Union has begun an appraisal of the pioneering Sputnik V coronavirus vaccine, developed by Moscow’s Gamaleya Institute, to determine whether the bloc will approve its use for immunizations.
On Thursday, a statement on the European Medicines Agency (EMA) website confirmed that the review had been ordered. According to officials, the “decision to start the rolling review is based on results from laboratory studies and clinical studies in adults.” The move comes after two member states unilaterally approved the jab without waiting for the regulator.
These studies, they add, “indicate that Sputnik V triggers the production of antibodies and immune cells that target the SARS-CoV-2 coronavirus and may help protect against COVID-19.” The EMA will now continue to evaluate data as it becomes available to determine whether “the benefits outweigh the risks.”
The rolling review, the regulator says, is being used “to speed up the assessment of a promising medicine during a public health emergency.” It allows consideration of the jab before all documentation is in place.
Kirill Dmitriev, the CEO of the Russian Direct Investment Fund (RDIF), which financed the development of the formula, said that “We have provided EMA with all the necessary data on the vaccine, which has already been approved by more than 40 countries around the world.”
“Sputnik V has the potential to make a critical contribution to saving millions of lives across Europe,” he said. “Vaccine partnerships must be above politics, and working with the EMA is a great example confirming that only by joining forces can we defeat the pandemic,” he added.
A number of EU member states have already approved the Russian-made jab on an individual basis, without waiting for the central regulator to conduct its review. Sputnik V is already registered in both Hungary and Slovakia.
Hungary’s prime minister, Viktor Orban, told journalists that politics shouldn’t be a factor in making potentially life-saving formulas available. “There is no Eastern or Western vaccine – there are only the good ones and bad ones,” he said. “The Hungarian health authorities have run their tests and guarantee the effectiveness of the vaccine.”
Think your friends would be interested? Share this story!
Better late than never? The European Union has begun an appraisal of the pioneering Sputnik V coronavirus vaccine, developed by Moscow’s Gamaleya Institute, to determine whether the bloc will approve its use for immunizations. Read Full Article at RT.com Read More
Russia was left embarrassed after EU foreign policy chief Borrell suddenly flipped the script on his views about bilateral relations upon returning back to the bloc after what Foreign Minister Lavrov had previously thought was his constructive visit to Moscow just days earlier, though this incident might hopefully provide the long-overdue impetus for Russia to […]
The amount of Russian fuel oil imported by Saudi Arabia between April and June of this year more than doubled compared to last year, Reuters reported Friday. “Data obtained by Reuters through Refinitiv Eikon ship tracking showed Saudi Arabia imported 647,000 tonnes (48,000 barrels per day) of fuel oil from Russia via Russian and Estonian ports in […]
As noted earlier, over the past centuries, there have been various assessments of changes in fertility and their impact on the state structure and social processes. Nevertheless, it has always been recognized that the demographic situation of a country is invariably a key indicator of its development. Therefore, the solution of the most important social […]
